Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sterically stabilized liposomes: physical and biological properties

M C Woodle1, M S Newman, J A Cohen

  • 1Liposome Technology, Inc., Menlo Park, CA 94025.

Journal of Drug Targeting
|January 1, 1994
PubMed
Summary

Surface modification of liposomes with polyethylene glycol (PEG) enhances drug delivery. Varying PEG molecular weight impacts liposome circulation time and tissue distribution, improving therapeutic efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.

NeuroImage. Clinical·2021
Same author

Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment and magnetic resonance imaging metrics.

European journal of neurology·2020
Same author

Knowledge of radiation legislation and guidelines amongst foundation doctors is inadequate for safe practice in the current era of radiology.

Clinical radiology·2019
Same author

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS).

Multiple sclerosis and related disorders·2015
Same author

Vocalizations in wild canids and possible effects of domestication.

Behavioural processes·2014
Same author

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.

Journal of neurology·2014

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Nanotechnology

Background:

  • Liposomal therapeutics benefit from surface modification for improved efficacy.
  • Polyethylene glycol (PEG) grafting on liposomes reduces rapid in vivo uptake and prolongs circulation.
  • PEGylation creates a steric barrier, potentially inhibiting plasma protein adsorption and opsonization.

Purpose of the Study:

  • To investigate the effect of varying polyethylene glycol (PEG) molecular weights on liposome coating thickness.
  • To correlate PEG molecular weight and coating thickness with liposome biodistribution and blood circulation.
  • To understand how surface polymer characteristics influence liposome-based drug delivery.

Main Methods:

  • Liposome surface modification using polyethylene glycol (PEG) of varying molecular weights (750 to 5000 Daltons).

Related Experiment Videos

  • Measurement of liposome coating thickness using physical studies, including electrophoretic mobility (zeta potential).
  • Assessment of tissue distribution in major phagocytic organs (liver and spleen).

    • Main Results:

    • Calculated coating thickness increases non-linearly with PEG molecular weight.
    • Liposome blood circulation and tissue distribution correlate with PEG-coating thickness, estimated via zeta potential.
    • Biological properties are primarily dictated by the surface polymer (PEG), not the lipid bilayer.

    Conclusions:

    • Liposome surface modification with PEGylation is crucial for advanced drug delivery.
    • PEG molecular weight is a critical parameter influencing liposome pharmacokinetics and biodistribution.
    • This approach offers advantages for controlling drug interaction and release without altering biodistribution.